Your browser doesn't support javascript.
loading
Refractory response to entrectinib for ROS-1 rearranged NSCLC with concurrent de novo TP53 mutation showing good response to CNS lesion, but poor duration of response: A case report.
Ito, Kentaro; Nishio, Miho; Fujiwara, Kentaro; Nishii, Yoichi; Ushiro, Kengo; Yasui, Hiroki; Hataji, Osamu.
Afiliação
  • Ito K; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Nishio M; Department of Biostatistics, Yokohama City University of Medicine, Yokohama, Japan.
  • Fujiwara K; Department of Clinical Laboratory, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Nishii Y; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Ushiro K; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Yasui H; Department of Clinical Laboratory, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Hataji O; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
Thorac Cancer ; 14(25): 2622-2626, 2023 09.
Article em En | MEDLINE | ID: mdl-37544307
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article